Hemadsorption as a Treatment Option for Multisystem Inflammatory Syndrome in Children Associated With COVID-19. A Case Report

Front Immunol. 2021 Jun 1:12:665824. doi: 10.3389/fimmu.2021.665824. eCollection 2021.

Abstract

Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19 is characterized by hypercytokinemia leading to overwhelming inflammation. We describe the use of a hemadsorption device as part of the supportive treatment for cytokine storm.

Keywords: SARS-CoV-2; cytokine - immunological terms; hemoadsorption; inflammatory multisystemic syndrome; myocardial injury.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • COVID-19 / complications*
  • COVID-19 / therapy
  • Hemoperfusion / methods*
  • Humans
  • Male
  • SARS-CoV-2
  • Systemic Inflammatory Response Syndrome / therapy*

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related